RELIANCE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RELIANCE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $14.81B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $17.03B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $14.09B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $8.81B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $10.97B | Feb 24, 2022 |
| FY2018 | Dec 31, 2018 | $2.81B | Feb 27, 2019 |
| FY2018 | Sep 30, 2018 | $2.97B | Feb 27, 2019 |
| FY2018 | Jun 30, 2018 | $2.99B | Feb 27, 2019 |
| FY2018 | Mar 31, 2018 | $2.76B | Feb 27, 2019 |
| FY2018 | Dec 31, 2017 | $2.38B | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.29B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $13.84B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $14.81B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $17.03B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $14.09B | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $2.13B | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $2.09B | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $2.02B | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $2.57B | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $2.45B | Feb 25, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.38B | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $2.45B | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $2.48B | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $2.42B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $2.06B | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $2.19B | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.20B | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $2.16B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $2.03B | Feb 24, 2017 |
| FY2016 | Sep 30, 2015 | $2.29B | Feb 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $703.60M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $676.10M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $614.70M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $780.70M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $794.20M | Feb 25, 2021 |
| FY2020 | Sep 30, 2019 | $814.70M | Feb 25, 2021 |
| FY2020 | Jun 30, 2019 | $853.60M | Feb 25, 2021 |
| FY2020 | Mar 31, 2019 | $866.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $709.80M | Feb 27, 2020 |
| FY2019 | Sep 30, 2018 | $834.30M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $739.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $875.20M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.34B | Feb 26, 2026 |
| FY2010 | Dec 31, 2010 | $194.35M | Feb 25, 2011 |
| FY2010 | Dec 31, 2009 | $148.16M | Feb 25, 2011 |
| FY2010 | Dec 31, 2008 | $482.78M | Feb 25, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.74B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.51B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.95B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $565.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.01B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $937.50M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $662.40M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $517.80M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.81B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.67B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.56B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.50B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.31B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.87B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $2.10B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.09B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.90B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.80B | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $831.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.43B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.67B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.12B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $799.40M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.17B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.30B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $664.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $399.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $626.50M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $328.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $430.60M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $468.80M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $341.80M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $236.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $172.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $242.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $239.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $161.60M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $154.90M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $10.02B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $10.48B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $10.33B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $9.54B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.11B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $8.13B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $8.04B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $7.75B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $7.41B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.79B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.75B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.23B | Feb 29, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.17B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $7.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.72B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.09B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.09B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.12B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $5.21B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $4.67B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.67B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.15B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.11B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.11B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.11B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.94B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $2.00B | Feb 24, 2022 |
| FY2021 | Dec 31, 2018 | $1.87B | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $1.84B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $1.83B | Feb 27, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.26B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $7.33B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.80B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.17B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.16B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.19B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $5.19B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $4.64B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.14B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $3.66B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $216.60M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $318.10M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.08B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.17B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $300.50M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $683.50M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $174.30M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $128.20M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $154.40M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $122.80M | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $1.94B | Feb 26, 2016 |
| FY2014 | Dec 31, 2014 | $2.32B | Feb 26, 2015 |
| FY2013 | Dec 31, 2013 | $2.11B | Feb 27, 2014 |
| FY2012 | Dec 31, 2012 | $1.21B | Feb 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 15 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 22 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 30 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 22 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 15 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 22 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 29 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 21 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51.74M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 53.72M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 57.27M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 58.79M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 61.81M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 63.60M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 66.85M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 66.88M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 72.61M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 72.68M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $108.70M | Feb 26, 2015 |
| FY2014 | Dec 31, 2013 | $96.90M | Feb 26, 2015 |
| FY2014 | Dec 31, 2012 | $60.20M | Feb 26, 2015 |
| FY2013 | Dec 31, 2011 | $35.90M | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $29.70M | Feb 27, 2013 |
| FY2011 | Dec 31, 2009 | $29.40M | Feb 24, 2012 |
| FY2010 | Dec 31, 2008 | $29.23M | Feb 25, 2011 |